Omnicell Inc

Company Profile

Omnicell Inc had its IPO on 2001-08-07 under the ticker symbol OMCL.

The company operates in the Healthcare sector and Health Information Services industry. Omnicell Inc has a staff strength of 3,780 employees.

Stock update

Shares of Omnicell Inc opened at $54.55 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $53.02 - $55.11, and closed at $53.42.

This is a -2.29% slip from the previous day's closing price.

A total volume of 508,890 shares were traded at the close of the day’s session.

In the last one week, shares of Omnicell Inc have slipped by -6.35%.

Omnicell Inc's Key Ratios

Omnicell Inc has a market cap of $2.47 billion, indicating a price to book ratio of 1.8695 and a price to sales ratio of 1.6519.

In the last 12-months Omnicell Inc’s revenue was $1.24 billion with a gross profit of $596.71 million and an EBITDA of $36.29 million. The EBITDA ratio measures Omnicell Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Omnicell Inc’s operating margin was -1.79% while its return on assets stood at -0.64% with a return of equity of -2.06%.

In Q2, Omnicell Inc’s quarterly earnings growth was a negative -61.8% while revenue growth was a negative 9.8%.

Omnicell Inc’s PE and PEG Ratio

Forward PE

29.4985

Trailing PE

0

PEG

2.28

Its diluted EPS in the last 12-months stands at $-0.5 per share while it has a forward price to earnings multiple of 29.4985 and a PEG multiple of 2.28. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Omnicell Inc’s profitability.

Omnicell Inc stock is trading at a EV to sales ratio of 1.8804 and a EV to EBITDA ratio of 16.9556. Its price to sales ratio in the trailing 12-months stood at 1.6519.

Omnicell Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$2.19 billion

Total Liabilities

$370.16 million

Operating Cash Flow

$-14817000.00

Capital Expenditure

$14.82 million

Dividend Payout Ratio

0%

Omnicell Inc ended 2023 with $2.19 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $2.19 billion while shareholder equity stood at $1.16 billion.

Omnicell Inc ended 2023 with $1.51 million in deferred long-term liabilities, $370.16 million in other current liabilities, 56000.00 in common stock, $379.18 million in retained earnings and $735.52 million in goodwill. Its cash balance stood at $399.46 million and cash and short-term investments were $399.46 million. The company’s total short-term debt was $10,951,000 while long-term debt stood at $568.11 million.

Omnicell Inc’s total current assets stands at $881.36 million while long-term investments were $35.04 million and short-term investments were $11.08 million. Its net receivables were $273.90 million compared to accounts payable of $47.19 million and inventory worth $130.58 million.

In 2023, Omnicell Inc's operating cash flow was $-14817000.00 while its capital expenditure stood at $14.82 million.

Comparatively, Omnicell Inc paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$53.42

52-Week High

$98.64

52-Week Low

$46.11

Analyst Target Price

$72.13

Omnicell Inc stock is currently trading at $53.42 per share. It touched a 52-week high of $98.64 and a 52-week low of $98.64. Analysts tracking the stock have a 12-month average target price of $72.13.

Its 50-day moving average was $63.21 and 200-day moving average was $60.18 The short ratio stood at 4.45 indicating a short percent outstanding of 0%.

Around 155.5% of the company’s stock are held by insiders while 10283.2% are held by institutions.